• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有记录的初始生长并不一定表明对散发性前庭神经鞘瘤的治疗。

Documented Initial Growth Does Not Necessarily Indicate Treatment for Sporadic Vestibular Schwannomas.

出版信息

Otol Neurotol. 2024 Sep 1;45(8):939-946. doi: 10.1097/MAO.0000000000004275.

DOI:10.1097/MAO.0000000000004275
PMID:39142316
Abstract

OBJECTIVE

To report the natural history of vestibular schwannoma (VS) who elected an initial period of observation and identify prognostic factors. To describe the natural history of growing VS, identify prognostic factors, and review the most recent literature.

STUDY DESIGN

Prospective cohort study and literature review.

SETTING

Tertiary referral center.

PATIENTS

Adult patients diagnosed with a VS between January 1998 and February 2023.

INTERVENTION

Magnetic resonance imaging surveillance.

MAIN OUTCOME MEASURES

Growth-free survival and subsequent growth-free survival considering significant growth as a change in size of ≥2 mm.

RESULTS

Of 430 patients undergoing observation with serial magnetic resonance imaging, 193 (44.9%) demonstrated significant growth at a median of 1.6 years (interquartile range, 0.94-3.51). Of the 193 patients who presented an initial episode of growth, 137 elected to continue to be observed. Of those, 83 (60.6%) presented a second episode of growth at a median of 1.43 years (interquartile range, 1.00-2.49). The subsequent growth-free survival rates (95% confidence interval) at 1, 3, 5, 7, and 10 years were 91.79% (87.26-96.56%), 64.44% (56.56-73.42%), 52.52% (44.23-62.35%), 42.23% (33.92-52.56%), and 36.11% (27.89-46.76%), respectively. Univariate and multivariate Cox regression analyses showed that EC tumor location and initial growth rate were significant predictors of subsequent growth.

CONCLUSIONS

Close observation after documentation of growth is an appropriate management in well-selected cases given that only around 56% of the tumor will continue to grow. Extracanalicular tumor location and initial growth rate are promising prognostic factors to help determine which patient would be a better candidate for close surveillance after initial documentation of growth.

摘要

目的

报告选择初始观察期的前庭神经鞘瘤(VS)的自然病史,并确定预后因素。描述生长性 VS 的自然病史,确定预后因素,并复习最新文献。

研究设计

前瞻性队列研究和文献复习。

设置

三级转诊中心。

患者

1998 年 1 月至 2023 年 2 月期间诊断为 VS 的成年患者。

干预

磁共振成像监测。

主要观察指标

无进展生存期和考虑到显著生长(大小变化≥2mm)的后续无进展生存期。

结果

在接受连续磁共振成像观察的 430 例患者中,193 例(44.9%)在中位数为 1.6 年(四分位距,0.94-3.51)时显示出显著生长。在最初出现生长的 193 例患者中,有 137 例选择继续观察。其中,83 例(60.6%)在中位数为 1.43 年(四分位距,1.00-2.49)时出现第二次生长。1、3、5、7 和 10 年的后续无进展生存率(95%置信区间)分别为 91.79%(87.26%-96.56%)、64.44%(56.56%-73.42%)、52.52%(44.23%-62.35%)、42.23%(33.92%-52.56%)和 36.11%(27.89%-46.76%)。单变量和多变量 Cox 回归分析表明,EC 肿瘤位置和初始生长率是后续生长的显著预测因素。

结论

在选择良好的情况下,在记录生长后进行密切观察是一种合适的治疗方法,因为只有约 56%的肿瘤会继续生长。管外肿瘤位置和初始生长率是有前途的预后因素,可以帮助确定哪些患者在初始生长记录后更适合密切监测。

相似文献

1
Documented Initial Growth Does Not Necessarily Indicate Treatment for Sporadic Vestibular Schwannomas.有记录的初始生长并不一定表明对散发性前庭神经鞘瘤的治疗。
Otol Neurotol. 2024 Sep 1;45(8):939-946. doi: 10.1097/MAO.0000000000004275.
2
Natural History of Growing Sporadic Vestibular Schwannomas: An Argument for Continued Observation Despite Documented Growth in Select Cases.散发性前庭神经鞘瘤的自然史:尽管在某些选定病例中观察到肿瘤生长,但仍应继续观察。
Otol Neurotol. 2020 Oct;41(9):e1149-e1153. doi: 10.1097/MAO.0000000000002756.
3
Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.散发型前庭神经鞘瘤自然史:肿瘤生长的容积学研究。
Otolaryngol Head Neck Surg. 2018 Sep;159(3):535-542. doi: 10.1177/0194599818770413. Epub 2018 Apr 24.
4
Delayed Tumor Growth in Vestibular Schwannoma: An Argument for Lifelong Surveillance.前庭神经鞘瘤生长延迟:终身监测的理由。
Otol Neurotol. 2019 Oct;40(9):1224-1229. doi: 10.1097/MAO.0000000000002337.
5
Spontaneous Volumetric Tumor Regression During Wait-and-Scan Management of 952 Sporadic Vestibular Schwannomas.952 例散发性前庭神经鞘瘤等待观察管理中自发体积肿瘤消退。
Otol Neurotol. 2022 Oct 1;43(9):e1034-e1038. doi: 10.1097/MAO.0000000000003651. Epub 2022 Aug 20.
6
Natural History of Growing Sporadic Vestibular Schwannomas During Observation: An International Multi-Institutional Study.观察期间散发性前庭神经鞘瘤生长的自然史:一项国际多机构研究。
Otol Neurotol. 2021 Sep 1;42(8):e1118-e1124. doi: 10.1097/MAO.0000000000003224.
7
Stratifying Risk of Future Growth Among Sporadic Vestibular Schwannomas.对散发性前庭神经鞘瘤未来生长风险进行分层。
Otol Neurotol. 2023 Aug 1;44(7):e519-e524. doi: 10.1097/MAO.0000000000003934. Epub 2023 Jun 23.
8
Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma.伽玛刀放射外科治疗散发性前庭神经鞘瘤后,预处理生长率作为肿瘤控制的预测指标。
J Neurosurg. 2017 Aug;127(2):380-387. doi: 10.3171/2016.5.JNS153013. Epub 2016 Nov 25.
9
Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.观察564例前庭神经鞘瘤的单机构经验:与肿瘤生长相关的因素
Otol Neurotol. 2016 Dec;37(10):1630-1636. doi: 10.1097/MAO.0000000000001219.
10
The Conditional Probability of Vestibular Schwannoma Growth at Different Time Points After Initial Stability on an Observational Protocol.基于观察性方案,初始稳定后不同时间点前庭神经鞘瘤生长的条件概率。
Otol Neurotol. 2020 Feb;41(2):250-257. doi: 10.1097/MAO.0000000000002448.